Articles

The stock of biotech Actinium Pharmaceutics Inc. tumbled 65% early Monday, after the Food and Drug Administration said a late-stage trial of its Iomab-B leukemia treatment is not enough to support a request for approval.

A report says Nvidia’s new Blackwell chip could be delayed by months, but one analyst says that could actually help gross margins.

German tire maker Continental on Monday said it may spin off the loss-making automotive electronics unit that employs 100,000 people.

Oil futures were sharply lower to begin the week on Monday, pulled down by a continued rout in global equity markets sparked by fears the U.S. economy may be heading toward recession.

FreshPet looks to buck the trend of a sharp selloff in the broader stock market.

The company said it has started commercializing variant-adapted COVID vaccines for the coming season, and is also building on development efforts for other drug candidates.

Expect U.S. stocks to rally after the November election — but a lot has to go right before that happens.

One of Wall Street’s more pessimistic analysts says evidence that the economy will slow further and pressure on the Fed to cut faster is a recipe for defensive stocks to shine and small caps to fade.

David Bianco, chief investment officer, Americas, for DWS, says the correction is “largely justified.”

“She has over $70,000 in her retirement fund, but says that’s for emergencies.”

Bond yields continued to reverse on Monday on growing expectations the Federal Reserve will cut aggressively — and possibly not even wait until its next scheduled meeting to do so.

If you’re looking for a luxurious Sin City home that doubles as the ultimate piece of sports memorabilia, we’ve found the place for you.